Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?
Raefa Abou Khouzam, Rania F. Zaarour, Klaudia Brodaczewska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1143-1143
Open Access | Times Cited: 50
Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer
Esther Strating, Mathijs Verhagen, Emerens Wensink, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 41
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 22
The regulatory roles and clinical significance of glycolysis in tumor
Qiqi Qiao, Shunfeng Hu, Xin Wang
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 761-786
Open Access | Times Cited: 10
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
Xinchen Tian, Tinghao Yan, Fen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy
Jie Li, Huamin Zeng, Luwei Li, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 24593-24618
Closed Access | Times Cited: 19
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 104-123
Closed Access | Times Cited: 18
Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models
Gonzalo Rodríguez‐Berriguete, Rathi Puliyadi, Nicole Machado, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
High hypoxia status in pancreatic cancer is associated with multiple hallmarks of an immunosuppressive tumor microenvironment
Hassan Sadozai, Animesh Acharjee, Hateem Zafar Kayani, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment
Carlos de la Calle‐Fabregat, Josep M. Calafell, Margaux Gardet, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 7
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Joanna Ciepła, Ryszard Smolarczyk
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Beta glucan as an immune stimulant in tumor microenvironment — Insight into lessons and promises from past decade
Vartika Mishra, Vachaspati Tripathi, Priyanka Yadav, et al.
International Journal of Biological Macromolecules (2023) Vol. 234, pp. 123617-123617
Closed Access | Times Cited: 14
Hypoxia-inducing cryogels uncover key cancer-immune cell interactions in an oxygen-deficient tumor microenvironment
Thibault Colombani, Zachary J. Rogers, Khushbu Bhatt, et al.
Bioactive Materials (2023) Vol. 29, pp. 279-295
Open Access | Times Cited: 14
Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma
Cristina-Stefania Dumitru, Marius Raica
Anticancer Research (2023) Vol. 43, Iss. 10, pp. 4315-4326
Open Access | Times Cited: 13
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
Ye Cao, Fansu Meng, Tiange Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 5
Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models
Tingmao Xue, Cherlie Lot Sum Yeung, Xiaowen Mao, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 78-92
Closed Access
Multifaceted TGF‐β signaling, a master regulator: From bench‐to‐bedside, intricacies, and complexities
Sana Ahuja, Sufian Zaheer
Cell Biology International (2023) Vol. 48, Iss. 2, pp. 87-127
Open Access | Times Cited: 11
Research progress in construction of organic carrier drug delivery platform using tumor microenvironment
Han Yan, Pengchao Xu, Hailin Cong, et al.
Materials Today Chemistry (2024) Vol. 37, pp. 101997-101997
Closed Access | Times Cited: 4
Pharmacological landscape of endoplasmic reticulum stress: uncovering therapeutic avenues for metabolic diseases
Ghallab Alotaibi, Abdullah Alkhammash
European Journal of Pharmacology (2025), pp. 177509-177509
Closed Access
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Raefa Abou Khouzam, Jean‐Maríe Lehn, Hemma Mayr, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1235-1235
Open Access | Times Cited: 10
Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
Alina L. Capatina, Jodie R. Malcolm, Jack Stenning, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells
Raefa Abou Khouzam, Mohak Sharda, R. Shyama Prasad Rao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top